HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Objective: To date, biomarkers are not routinely used in endometrial cancer diagnosis, prognosis, and follow-up. The purpose of this study was to evaluate whether serum HE4 was related to clinicopathological risk factors and outcome. Second, the role of serum HE4 and CA125 was assessed as indicator...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IOS Press
2018-02-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428318757103 |